Purchase Order 36C25624P0025
- Not listed
- This is a $204,558.17 firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The contract is for Ventana reagents, which are likely related to Roche's Ventana staining systems used for pathology and clinical diagnostics. The order was placed under a larger Indefinite Delivery Vehicle (IDV) contract, potentially a Blanket...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $1,506,061.00 contract is for the provision of instrumentation and reagents to perform immunohistochemical (IHC) and histology special staining cost per test services, with a period of performance...
- This is a $1,799,245.83 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and related medical products. The contract is for the delivery of unspecified REAGENTS with an ultimate completion date of August 10, 2024. Roche Diagnostics is an experienced federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across...
- The Department of Veterans Affairs Veterans Health Administration awarded a $238,443.21 Firm Fixed Price Purchase Order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide VENTANA REAGENTS. This order does not have a set-aside designation. Roche Diagnostics provides a variety of laboratory instruments, reagents, test kits, and associated products and services to federal agencies, including the VA, Department of Defense, Department of Health and Human Services,...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency, to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, which does not have a set-aside designation, has a ceiling value of $468,723.11 and a period of performance through September 30, 2029. Roche Diagnostics Corporation provides a wide range of medical diagnostic...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $157,436.96 contract, which did not have a set-aside designation, was for immunohistochemistry products and services. Roche Diagnostics has been awarded numerous federal contracts to provide medical equipment, supplies, and services to agencies such...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22), a division of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $687,960.22, is for the delivery of IHC (Immunohistochemistry) reagents. The contract has an ultimate completion date of June 11, 2026. Roche Diagnostics Corporation is a...
- This firm-fixed-price delivery order contract was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 8, to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $62,676.00, is for immunohistochemical special stains services, with a period of performance through February 1, 2024. Roche Diagnostics is a...
- This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $116,048.25 contract provides Roche Diagnostics' reagents for the VA's Veterans Health Administration facilities. Roche Diagnostics has a history of providing critical care medical equipment, reagents, and testing services to federal...
This is a $149,329.59 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of immunohistochemical and special stain reagents by Roche Ventana and was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 16. The contract has an ultimate completion date of September 30, 2024 and was not set aside for any special business category. Roche Diagnostics holds multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies, including the Department of Defense and the Department of Veterans Affairs, for a wide range of laboratory equipment, reagents, and associated medical diagnostic products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($161) | 6/4/25 | |
| P00001 | Funding Only Action | ($43k) | 9/16/24 | |
| Not listed | Not listed | $192.8k | 10/1/23 |